Journal profile · RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
ISSN 1824-4785 · eISSN 1827-1936 · Edizioni Minerva Medica S.p.A. · ITALY
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.38; hybrid open access; review over 12 weeks (community reports); community-reported acceptance: fairly easy; 36 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING is published by Edizioni Minerva Medica S.p.A. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Medical Imaging Techniques and Applications, Radiopharmaceutical Chemistry and Applications and Radiomics and Machine Learning in Medical Imaging, together about 36.9% of its articles. Its main subfields are Radiology, Nuclear Medicine and Imaging. (generated from OpenAlex topic counts and CAS ranking data)
The Quarterly Journal of Nuclear Medicine and Molecular Imaging publishes scientific papers on clinical and experimental topics of nuclear medicine. Manuscripts may be submitted in the form of editorials, original articles, review articles and special articles. The journal aims to provide its readers with papers of the highest quality and impact through a process of careful peer review and editorial work.
Source: LetPub
Research area (LetPub): RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Editor-in-chief Michael KreisslPublisher website
Editorial board by country: 3 in mainland China (about 5%); most named Italy 14, Germany 7, United States 5, France 5, Mainland China 3 (57 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Medical Imaging Techniques and ApplicationsMedicine18.2%
- Radiopharmaceutical Chemistry and ApplicationsMedicine12.1%
- Radiomics and Machine Learning in Medical ImagingMedicine6.7%
- Prostate Cancer Treatment and ResearchMedicine6.2%
- Thyroid Cancer Diagnosis and TreatmentMedicine5.8%
- Orthopedic Infections and TreatmentsMedicine4.6%
- Medical Imaging and Pathology StudiesMedicine3.8%
- Advanced Radiotherapy TechniquesPhysics and Astronomy3.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.38LetPub ·
- Impact factor (publisher)
- 1.4Publisher website ·
- CiteScore 2026-06
- 3LetPub ·
- SJR 2026-06
- 0.35LetPub ·
- SNIP 2026-06
- 0.48LetPub ·
- h-index
- 57LetPub ·
- h-index
- 24OpenAlex ·
- i10-index
- 103OpenAlex ·
- 2-year mean citedness
- 1.88OpenAlex ·
- Self-citation rate
- 7.1%LetPub ·
- Share of gold OA articles
- 5.68%LetPub ·
Volume
- Articles per year
- 30LetPub ·
Articles by year OpenAlex count · 400 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 24 | 2 | 12 |
| 2025 | 36 | 11 | 77 |
| 2024 | 24 | 2 | 69 |
| 2023 | 18 | 4 | 117 |
| 2022 | 66 | 9 | 364 |
| 2021 | 46 | 7 | 321 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Edizioni Minerva Medica S.p.A.
- Country or region
- ITALY
- Language
- English
- ISSN
- 1824-4785
- Electronic ISSN
- 1827-1936
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
FAQ
Frequently asked questions about QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
What CAS zone is QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING in?
In the 2025 upgraded edition of the CAS Journal Ranking, QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING is in Zone 4 of Medicine, and in Zone 4 of the minor category Radiology, Nuclear Medicine & Medical Imaging. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING?
The latest impact factor listed by LetPub is 1.38; CiteScore 3, h-index 24.
How long does peer review take at QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING?
Authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING based?
Of the 57 board members whose country the journal's board page names, 3 (about 5%) are in mainland China; the countries named most often are Italy (14), Germany (7) and United States (5). Counted from the institutions listed on the board page; for reference only.
Which databases index QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING?
According to LetPub and DOAJ records, QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING is indexed in SCIE and Scopus.
Is QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING open access, and what is the APC?
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .